Exchange: NASDAQ·Updated 11:48 AM EDT
ENTX logo

ENTX Entera Bio Ltd

$2.93
$0.035
(1.18%)
Today
EarningsNov 13
Mkt Cap$514.55M
Vol95,410.00

About ENTX

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
46

Neutral Sentiment

How do you feel about ENTX?

Advertisement|Remove ads.